axoServices™ custom laboratory services
At Axol Bioscience we believe that iPSCs have the potential to transform drug discovery.
Explore our current missions:
World leaders in iPSC technology supporting the next generation of advanced models for drug discovery
We provide biopharma and virtual organizations with human iPSC-derived cells and outsourced laboratory services to support drug discovery in the neurodegenerative, neuroinflammatory, and cardiotoxicity areas.
As leaders in human induced pluripotent stem cell (iPSC) products and services, we support the pursuit of more human-relevant in vitro models to develop better, safer therapies. We have over a decade of experience supplying top ten Biopharma institutions and drug discovery companies with robust, high-quality in vitro models and custom lab services.
Our industry-leading iPSC capabilities support the pursuit of advanced in vitro disease models and supply volume for organ-on-a-chip devices and microfluidics platforms. From simple monoculture models to complex co- and tri-culture and 3D models, we continue to pioneer the advanced utility of iPSCs for research and drug discovery.
With a focus on neurodegenerative diseases and cardiotoxicity, we offer our experience and expertise across three main capabilities:
axoServices™
axoLines™
axoCells™
axoServices™ — custom laboratory services
Outsource your iPSC project to the experts
A full suite of custom lab service projects comprising Reprogramming, Differentiation, Gene Editing, Compound Screening, Multi-Electrode Array and Cell Assays. With over a decade of iPSC expertise, you can rely on us for a professional, high-quality service delivery and an ongoing collaborative relationship.
Find us on Scientist.com, the world’s leading platform for CROs.
axoLines™ – human-derived cell lines
iPSC derived lines from patient and control human donors
Our iPSC library derived from a range of consented patient and healthy donors. Our axoLines iPSCs are used for axoServices custom lab services, made-to-order axoCells projects and specific licensing arrangements. Key therapy areas include Alzheimer’s Disease, Parkinson’s Disease, ALS, Huntington’s Disease, Friedrich’s Ataxia and Frontotemporal Dementia.
axoCells™ — cells, media and reagents
Human iPSC derived cells to model human disease
Our catalogue of robust, highly relevant iPSC-derived neurons and cardiomyocytes developed at our ISO 9001:2015 accredited production facility. Leading neuronal cell types include: cortical excitatory neurons, striatal neurons, cortical inhibitory interneurons, microglia, astrocytes, sensory neurons and motor neurons. We also provide high-quality atrial cardiomyocytes and ventricular cardiomyocytes.
